mRNA |
Irinotecan |
gCSI |
pan-cancer |
AAC |
0.13 |
0.01 |
mRNA |
lovastatin |
CTRPv2 |
pan-cancer |
AAC |
-0.095 |
0.01 |
mRNA |
leptomycin B |
CTRPv2 |
pan-cancer |
AAC |
0.087 |
0.01 |
mRNA |
crizotinib:PLX-4032 (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.088 |
0.01 |
mRNA |
tanespimycin:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.096 |
0.02 |
mRNA |
PIK-93 |
GDSC1000 |
pan-cancer |
AAC |
0.076 |
0.02 |
mRNA |
avicin D |
CTRPv2 |
pan-cancer |
AAC |
-0.14 |
0.02 |
mRNA |
BRD4132 |
CTRPv2 |
pan-cancer |
AAC |
0.096 |
0.02 |
mRNA |
doxorubicin:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.081 |
0.02 |
mRNA |
ML162 |
CTRPv2 |
pan-cancer |
AAC |
-0.084 |
0.02 |